about
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.A microfluidic device for label-free, physical capture of circulating tumor cell clusters.Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.AR Expression in Breast Cancer CTCs Associates with Bone Metastases.Sestrin1, a tumor suppressor that can be rescued.Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains
P50
Q34111187-22FB74F9-95FA-4B54-A2D5-E83967033572Q35174681-22C8BD7D-92B6-4D62-9D04-7F8554A5369DQ35812039-CA45E109-4E8D-41B5-AA22-F74802EEC394Q41438291-2990AB69-0AF9-4B9C-AD39-A59FE82ADC5CQ49913672-54D2033F-4E94-4E1D-B13A-57C2B15BD671Q50056038-CC2746C6-6A50-4A85-84C3-4B4003C10FD5Q54119905-02E4086B-0024-48E3-B9C5-AA0D8C7DDECBQ62766307-B10B1012-9F29-487E-BD4D-9DD28E8798A8
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria C Donaldson
@nl
Maria Donaldson
@en
type
label
Maria C Donaldson
@nl
Maria Donaldson
@en
altLabel
Maria C Donaldson
@en
prefLabel
Maria C Donaldson
@nl
Maria Donaldson
@en
P106
P21
P31
P496
0000-0001-6403-6713